Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

Europe - EPA:ALTUV - FR0013345493 - Common Stock

1.686 EUR
+0 (+0.12%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALTUV. ALTUV was compared to 103 industry peers in the Machinery industry. ALTUV has a bad profitability rating. Also its financial health evaluation is rather negative. ALTUV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALTUV had negative earnings in the past year.
In the past year ALTUV had a positive cash flow from operations.
Each year in the past 5 years ALTUV has been profitable.
ALTUV had a positive operating cash flow in 4 of the past 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

ALTUV has a worse Return On Assets (0.05%) than 70.87% of its industry peers.
With a Return On Equity value of 0.10%, ALTUV is not doing good in the industry: 70.87% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 3.03%, ALTUV is not doing good in the industry: 68.93% of the companies in the same industry are doing better.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.77%.
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROIC 3.03%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of ALTUV (0.08%) is worse than 70.87% of its industry peers.
In the last couple of years the Profit Margin of ALTUV has declined.
With a Operating Margin value of 5.39%, ALTUV perfoms like the industry average, outperforming 45.63% of the companies in the same industry.
ALTUV's Operating Margin has improved in the last couple of years.
ALTUV's Gross Margin of 37.34% is in line compared to the rest of the industry. ALTUV outperforms 47.57% of its industry peers.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
Industry RankSector Rank
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTUV is destroying value.
The number of shares outstanding for ALTUV has been reduced compared to 1 year ago.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
Compared to 1 year ago, ALTUV has an improved debt to assets ratio.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.44, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.44, ALTUV is not doing good in the industry: 62.14% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALTUV is 4.83, which is a neutral value as it means it would take ALTUV, 4.83 years of fcf income to pay off all of its debts.
ALTUV has a Debt to FCF ratio of 4.83. This is comparable to the rest of the industry: ALTUV outperforms 57.28% of its industry peers.
ALTUV has a Debt/Equity ratio of 0.57. This is a neutral value indicating ALTUV is somewhat dependend on debt financing.
The Debt to Equity ratio of ALTUV (0.57) is worse than 62.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Altman-Z 1.44
ROIC/WACC0.46
WACC6.62%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALTUV has a Current Ratio of 1.64. This is a normal value and indicates that ALTUV is financially healthy and should not expect problems in meeting its short term obligations.
ALTUV's Current ratio of 1.64 is in line compared to the rest of the industry. ALTUV outperforms 57.28% of its industry peers.
A Quick Ratio of 0.84 indicates that ALTUV may have some problems paying its short term obligations.
ALTUV has a Quick ratio of 0.84. This is in the lower half of the industry: ALTUV underperforms 62.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.84
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

ALTUV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.19%.
Measured over the past years, ALTUV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.42% on average per year.
ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -8.23%.
Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%

3.2 Future

The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-49.94%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 32.74, ALTUV can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit more expensive than 74.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. ALTUV is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 32.74
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTUV is valued a bit cheaper than 63.11% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaply inside the industry as 93.20% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.81
EV/EBITDA 8.07
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.08%
EPS Next 3Y14.51%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.50%, ALTUV has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.88, ALTUV pays a bit more dividend than its industry peers.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (9/15/2025, 7:00:00 PM)

1.686

+0 (+0.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-03 2025-04-03/amc
Earnings (Next)09-17 2025-09-17
Inst Owners6.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.86M
Analysts86.67
Price Target3.06 (81.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-74.97%
EPS NY rev (3m)-74.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.2%
Revenue NY rev (3m)-12.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.74
P/S 0.6
P/FCF 4.81
P/OCF 3.46
P/B 0.73
P/tB N/A
EV/EBITDA 8.07
EPS(TTM)0
EYN/A
EPS(NY)0.05
Fwd EY3.05%
FCF(TTM)0.35
FCFY20.8%
OCF(TTM)0.49
OCFY28.93%
SpS2.8
BVpS2.31
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROCE 4.13%
ROIC 3.03%
ROICexc 3.28%
ROICexgc 14.19%
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
FCFM 12.54%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexcg growth 3Y38.43%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Debt/EBITDA 3.4
Cap/Depr 58.57%
Cap/Sales 4.9%
Interest Coverage 250
Cash Conversion 126.83%
Profit Quality 15804.5%
Current Ratio 1.64
Quick Ratio 0.84
Altman-Z 1.44
F-Score5
WACC6.62%
ROIC/WACC0.46
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
EPS Next Y-49.94%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y-7.12%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year209.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.04%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y10.6%
OCF growth 3Y27.9%
OCF growth 5YN/A